SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-035067
Filing Date
2014-10-30
Accepted
2014-10-30 18:49:07
Documents
1
Period of Report
2014-10-30

Document Format Files

Seq Description Document Type Size
1 OCLASSEN FINAL FORM 4 rrd417593.html 4  
1 OCLASSEN FINAL FORM 4 rrd417593.xml 4 24668
  Complete submission text file 0001181431-14-035067.txt   26138
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3290 WEST BAYSHORE RD PALO ALTO CA 94303
Business Address
OCLASSEN GLENN A (Reporting) CIK: 0001210529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36066 | Film No.: 141184424